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Objective: To describe characteristics, presentation, time to diagnosis and diagnostic findings of patients with 
intestinal tuberculosis (ITB) in a low-burden country. 
Method: Retrospective study of 61 consecutive ITB patients diagnosed between 2008-2014 at a large East 
London hospital.  
Results: 40 of 61 patients were male. Mean age was 34.6 years. 93% of patients were born abroad, mostly 
from TB-endemic areas (Indian subcontinent: 88%, Africa: 9%). 25% had concomitant pulmonary TB. Median 
time from symptom onset to ITB diagnosis was 13 weeks (IQR 3-26 weeks). Ten patients were initially treated 
for IBD, although patients had ITB. The main sites of ITB involvement were the ileocaecum (44%) or small 
bowel (34%). Five patients had isolated perianal disease. Colonoscopy confirmed a diagnosis of ITB in 77% of 











This article is protected by copyright. All rights reserved. 
Conclusion: Diagnosis of ITB is often delayed, which may result in significant morbidity. ITB should be excluded 
in patients with abdominal complaints who come from TB-endemic areas to establish prompt diagnosis and 
treatment. Diagnosis is challenging but aided by axial imaging, colonoscopy and tissue biopsy for TB culture 
and histology. 
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INTRODUCTION 
Tuberculosis (TB) may involve any part of the gastrointestinal (GI) tract and intestinal TB (ITB) accounts for 2% 
of TB cases worldwide1. 58% of TB patients in the United Kingdom (UK) present with extra-pulmonary disease, 
5.9% have ITB2. East London has one of the highest rates of TB in Europe (85.6 cases per 100,000 population in 
20152) and serves a large migrant population from the Indian subcontinent and Africa. ITB presents a diagnos-
tic challenge, given its non-specific clinical presentation and tendency to mimic other abdominal pathologies 
such as IBD3 and malignancy4, 5. Misdiagnosis rates have been as high as 50-70% even in TB-endemic coun-
tries6. Patients with ITB often suffer from delays in diagnosis and initiation of anti-tuberculous therapy (ATT) 
leading to significant morbidity and mortality, especially when immunosuppressive therapy is administered for 
presumed IBD7, 8.  
 In this paper we describe characteristics, presentation, time to diagnosis and diagnostic findings of pa-
tients with intestinal tuberculosis (ITB) in a low-burden country. 
 
METHODS 
We conducted a retrospective study of all consecutive patients who were diagnosed with ITB between January 
2008 and December 2014 at two large teaching hospitals in East London, UK. Information on patient de-
mographics, site of ITB and clinical, radiological, bacteriological and histological findings were collated from 
electronic patient records. Details of ATT including duration, complications and treatment outcome were rec-
orded. Statistical analysis was performed using χ², Mann-Whitney U, t-test and Pearson’s Correlation Coeffi-
cient. As per UK health research authority guidelines, ethical approval was not required for this study. 
 
RESULTS 
Of the 147 patients diagnosed with abdominal TB, 61 had TB affecting the GI tract. 40 were male. Mean age 
was 34.6 (range 13-82) years. 93% of patients were born abroad, with the majority from TB-endemic countries 
(88% from the Indian subcontinent, 9% from Africa). Patients had been residing in the UK for a median of 5 
years prior to diagnosis (IQR 2–11.75 years). Two patients had confirmed human immunodeficiency virus (HIV) 
infection. 25% had coexisting pulmonary TB. Time from self-reported symptom onset to ITB diagnosis varied, 
with a median of 13 weeks (IQR 3-26 weeks) (Table 1). The most common presenting complaints were ab-
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(Table 2). Three patients presented with weight loss, fevers and night sweats but no abdominal symptoms.  
 Nineteen patients were initially diagnosed with IBD. Four patients were investigated for colorectal cancer 
and 4 patients were suspected to have lymphoma. Four patients were diagnosed with appendicitis. Three were 
diagnosed with gastritis and three with a urinary tract infection (UTI) at first presentation.  
 Patients with ITB diagnosed at first presentation to our institution (n=23) were less likely to have been in-
vestigated previously for IBD or other intestinal diseases (p=0.007 and p=0.001 respectively) than those with 
ITB diagnosed on subsequent visits (n=38). Characteristics of patients diagnosed with ITB at the initial visit ver-
sus those diagnosed subsequently are presented in Table 3. Patients not diagnosed at the initial visit were 
more likely to develop intestinal obstruction (p=0.04). The patients diagnosed with ITB on their first visit were 
more likely to be hospitalized when diagnosis was made (p=0.05) and develop more surgical complications 
(iatrogenic bowel perforation, wound dehiscence, peritonitis, adhesions) (p=0.02). Duration of symptoms did 
not influence outcomes between the group of patients diagnosed at first visit or subsequent visits (p=0.45). 
There was no correlation between time since entry to the UK and time to diagnosis between the two groups 
(p=0.26). 
 Sites of TB involvement were predominantly the ileocaecal region (44%) and small bowel (34%). The colon 
was affected in 16 cases, 5 patients had isolated perianal disease and 2 had appendiceal TB. All but 6 of our pa-
tients underwent computerised tomography (CT) or magnetic resonance imaging (MRI) of the abdomen, 4 of 
whom had isolated perianal disease. The most common CT findings were bowel wall thickening (33 patients), 
intra-abdominal lymphadenopathy (24 patients), intra-abdominal collection (11 patients) or peritoneal thick-
ening (7 patients). MRI of the abdomen showed fistulae (3 patients) or inflammation of the ileum (2 patients). 
Eight patients had ultrasound examinations, in 4 patients ascites was present and 4 patients had bowel wall 
thickening. 17 of 42 (40%) had positive histology showing granulomatous changes and necrosis and 28 of 55 
(51%) were culture positive for Mycobacterium tuberculosis. Three of 61 patients (5%) had isoniazid-resistant 
TB. All patients with perianal TB were diagnosed from histology and/or microbiology.  
 Eleven patients had an interferon gamma release-assay (IGRA) performed; 9 of these were positive. Fif-
teen patients had a tuberculin skin test (TST), which was positive in 13 cases. 
 Thirty-one patients underwent ileocolonoscopy and 4 underwent gastroscopy. Gastroscopy failed to show 
any findings associated with ITB. Colonoscopy helped to confirm the diagnosis in 24 out of 31 patients (77%). 
The most common findings on endoscopy were ileocaecal inflammation (18 patients), ileocaecal ulceration (4 
patients) and ileal strictures (4 patients). 20 of 61 patients underwent abdominal surgery (13 underwent lapa-
roscopy, 7 underwent laparotomy). Of the 9 diagnostic laparoscopies performed, 7 laparoscopies yielded posi-
tive histology and 4 cultured M. TB from pus, ascitic fluid or omental biopsies. Five of 20 patients developed 
complications from surgery: faecal peritonitis (2 patients), wound dehiscence (2 patients), adhesions (2 pa-
tients) and iatrogenic perforation (1 patient)  (Table 3). 
 Twenty of 61 patients did not undergo diagnostic endoscopy or surgery (33%); of those, 4 underwent 
analysis of ascitic or pleural fluid and 5 had radiologically guided biopsy of intra-abdominal masses, or aspira-
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or sputum. Three patients were diagnosed based on radiology and a positive IGRA or TST, two patients were 
diagnosed on imaging alone in combination with symptoms consistent with TB. One patient had an incidental 
diagnosis based on histology of tissue removed during an elective hernia repair showing granulomatous 
change.  
 Thirty-five of 61 patients received 6 months of treatment, 21 of 61 patients received more than 6 months 
of ATT, most often due to persistence of symptoms. 58 patients (95%) received standard treatment with ri-
fampicin, isoniazid, pyrazinamide and ethambutol. Isoniazid-resistant M. TB was found in 3 patients (5%), and 
these patients received moxifloxacin instead of isoniazid. One patient was treated with corticosteroids (pred-
nisolone) in addition to ATT. Four patients were lost to follow-up and one died during treatment. Perianal TB 
was treated for longer (mean 10 months) than ITB without perianal involvement (mean 7.2 months) (p=0.004). 
 
DISCUSSION 
Our study confirms that ITB is a disease that predominantly affects younger adults9-12. Most of our patients 
were from countries with high TB prevalence presenting with abdominal symptoms7, 13. It is recognised in the 
literature that patients with abdominal TB may present with few or no abdominal symptoms, making diagnosis 
challenging14.  
 Median symptom duration in our patients (13 weeks) was similar to other studies, which reported ranges 
between 6 weeks and 3 months7, 8. In our cohort, there was no correlation between length of stay in the UK 
and time to diagnosis (p=0.14). There was no correlation between length of time to diagnosis in patients with 
pulmonary TB (mean 24.2 weeks) and those without pulmonary TB (mean 23 weeks) (p=0.46).  
 The predominant ileocaecal involvement in ITB is thought to be due to the relative abundance of lym-
phoid tissue in this area and stasis of faecal matter, increased absorption and close proximity of bacilli to the 
mucosa15. The slow downstream movement of this bacillus-rich faecal matter may explain why the colon is al-
so commonly affected15, 16.  
 Five patients in our cohort presented with perianal TB and all had positive histology showing granuloma-
tous changes and cultured M.TB. Perianal TB may be confused with a simple fistula-in-ano or isolated perianal 
Crohn’s disease17 and therefore anal biopsies and/or pus should always be sent for TB culture in patients origi-
nating from high-incidence countries. 
 Abdominal CT findings in ITB patients include bowel wall thickening, abdominal lymphadenopathy with 
central necrosis, intra-abdominal collections and peritoneal inflammation9, 16, 18, 19. MRI of the abdomen is able 
to delineate peritoneal inflammation through intermediate changes in signal densities20 and was used in three 
of our patients. Ultrasound is often limited by the presence of bowel gas and was only used in 8 of our pa-
tients. However, ultrasound is low cost, rapid and useful to detect small bowel strictures, omental changes and 
ascites21. 
 IGRA and TST are not routinely recommended as part of the diagnostic strategy for active TB due to their 
poor sensitivity and specificity 9, 22, 23. Reported rates of ITB diagnosis from histopathology specimens are 54% 
and microbiological confirmation has been reported as between 18%-50%11, 24-26. Histology had a lower diag-
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agnosis in any of the four patients on which it was performed as TB is unlikely to affect the upper GI tract15. 
Colonoscopy aided diagnosis in 77% of those performed, highlighting the importance of performing endoscopy 
on suspected ITB patients. If possible, colonoscopy should be performed in all patients with ITB since it pro-
vides direct visualisation of mucosal lesions and strictures, as well as allowing tissue biopsy for histology and 
TB culture18, 27. Findings such as terminal ileitis with ulceration, pseudodiverticulae and atrophic mucosal areas 
should raise suspicions for ITB14.  
 Laparoscopy is a rapid, safe and effective technique with a sensitivity of up to 92% for diagnosis of ab-
dominal TB, but there is no evidence as to its utility for diagnosis of ITB without peritoneal involvement28, 29. 
Nine of our patients underwent diagnostic laparoscopy, 7 of which resulted in histological confirmation of dis-
ease and 4 cultured M. TB from samples obtained from omental or peritoneal biopsy.  
 ITB typically responds to medical management and early initiation of treatment may help to prevent sur-
gical complications15. Tuberculous obstruction is considered the most common complication (24%) and carries 
a high morbidity, particularly in developing countries13, 30. It has been suggested that obstructing lesions <12cm 
may be managed without the need for surgery31. Perforation leads to high levels of mortality and is reported 
to complicate ITB in up to 11% of adult cases. Our perforation rate was slightly higher (13%), which may be at-
tributable to the late presentation of many of our patients32. 
 Of 61 patients, 3 had isoniazid-resistant TB, emphasizing the need for obtaining biopsies for culture 
whenever possible. As reported in other studies, treatment of abdominal TB was often extended for up to 12 
months15, 33. However, recent evidence has demonstrated that there is not always benefit in extending therapy 
beyond 6 months11. While other centres have reported using corticosteroids for those with non-resolving ob-
struction34, 35, only one of our patients received prednisolone in addition to ATT. Therapeutic drug monitoring 
(TDM) is indicated in ITB, as GI inflammation may lead to malabsorption and therefore reduced serum drug 
levels. TDM may guide the clinician on dosing regimes and duration of treatment36. 
 Those patients that were not diagnosed with ITB on their initial visit were more likely to have an initial di-
agnosis of IBD. Differentiating between IBD and ITB is challenging, however both disease entities display dif-
ferent clinical, radiological and endoscopic features. Clinically, patients with ITB present more often with low-
grade fever, night sweats and possibly respiratory symptoms than patients with IBD. Crohn’s patients are more 
likely to have haematochezia than those with ITB37-41. Radiologically, ITB patients are more likely to have ab-
dominal lymphadenopathy and ascites, whereas those with Crohn’s are more likely to display the “comb sign” 
(vascular engorgement of the mesentery)42. Endoscopy often shows circular or transverse ulcers and an in-
creased number of granulomata in patients with ITB, whereas patients with Crohn’s disease usually have an in-
creased number of “skip” lesions spread throughout the GI tract with longitudinal ulcers predominating. The 
presence of cobblestoning is almost pathognomonic for Crohn’s39-41, 43-45.  
 Although this study was done retrospectively, it presents one of the largest case series of patients with 
ITB compared to previous studies conducted in low and high incidence countries7-10, 12, 18, 46-50.  Future large 
prospective studies are needed in order to develop diagnostic algorithms that would facilitate early diagnosis 










This article is protected by copyright. All rights reserved. 
physicians, radiologists, histopathologists and microbiologists in a multidisciplinary setting is essential to iden-
tify patients with ITB and initiate early treatment. 
 
CONCLUSION 
ITB is a rare disease and may be confused with other abdominal diseases including IBD, intestinal infections 
and colonic malignancies. Clinicians should have a high index of suspicion for ITB in patients from high TB prev-
alence countries presenting with abdominal symptoms in order to prevent complications resulting from de-
layed diagnosis. A combination of diagnostic modalities such as cross-sectional imaging, colonoscopy and lapa-
roscopy should be employed, and appropriate tissue obtained for histological confirmation and TB culture. 
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Table 1. Demographics of patients with intestinal tuberculosis (ITB). (Total number of patients = 61) 
 












Place of birth  










Median length of stay in the UK before di-
agnosis  (years)  
5 (IQR 2-11.75) 
Median duration of symptoms prior to diag-
nosis (weeks) 
13 (IQR 2-26) 
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Table 2. Presenting symptoms at time of diagnosis in patients with intestinal tuberculosis (ITB) 
 
Symptoms at time of diagnosis* Number of patients (n=61)  
Gastrointestinal  Abdominal pain 
Nausea/ vomiting 





19  (31%) 
15  (24%) 
3    (5%) 
2    (3%) 
Respiratory  Cough 
Dyspnoea 
 
5    (8%) 
1    (2%) 




36  (59%) 
12  (19%) 
11 (18%) 
 
*Most patients complained of >1 symptom 
 
Table 3. Patients diagnosed at first presentation to our hospitals vs. patients diagnosed at a later date 
 Patients diagnosed at 
first visit  
(n=23) 
Patients diagnosed 





Treated for alternative diagnosis other 
than ITB 
 

















Mean duration of symptoms before 
diagnosis of ITB (weeks) 
20.7  24.8  n/a 0.45 
Perianal TB 1 4 5 0.72 














ITB: intestinal tuberculosis; IBD: inflammatory bowel disease; TB: tuberculosis.  



























Hospitalized at time of diagnosis 22 27 49 0.05 





Abdominal surgical procedures (total) 
 
Diagnostic laparoscopy 
Laparoscopy for ITB complications 



















































Mean treatment duration (months) 7.8 6.9 n/a 0.09 
Deaths during treatment 0 1 1 0.43 
